Economic Evaluation of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in Canada
- 1 January 2000
- journal article
- Published by Elsevier in Value in Health
- Vol. 3 (1) , 31-39
- https://doi.org/10.1046/j.1524-4733.2000.31004.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalThe Lancet, 1996
- A New Decision Model for Cost-Utility Comparisons of Chemotherapy in Recurrent Metastatic Breast CancerPharmacoEconomics, 1996
- Key Issues in the Treatment of Advanced Breast CancerPharmacoEconomics, 1996
- Systemic Therapy in Breast CancerPharmacoEconomics, 1994
- Postmenopausal Breast CancerDrugs & Aging, 1993
- Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis modelBreast Cancer Research and Treatment, 1993
- Breast CancerNew England Journal of Medicine, 1992
- Management of early breast cancer.BMJ, 1992
- Systemic Therapy of Advanced Breast CancerDrugs, 1992
- Efficacy and Cost Effectiveness of Adjuvant Chemotherapy in Women with Node-Negative Breast CancerNew England Journal of Medicine, 1991